<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Risk of malignancy in thyroid nodules in children and adolescents, based on the result of a fine-needle aspirate</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Risk of malignancy in thyroid nodules in children and adolescents, based on the result of a fine-needle aspirate</h1>
<div class="graphic"><div class="figure"><div class="ttl">Risk of malignancy in thyroid nodules in children and adolescents, based on the result of a fine-needle aspirate</div><div class="cntnt"><table cellspacing="0"><colgroup span="9" width="11%"></colgroup> <tbody> <tr> <td class="subtitle1">Overall average percent range of subjects with malignancy*</td> <td class="subtitle1">Number of subjects</td> <td class="subtitle1">Subjects with histology confirmed</td> <td class="subtitle1">Nondiagnostic<br/> (Category I)</td> <td class="subtitle1">Benign<br/> (Category II)</td> <td class="subtitle1">AUS/FLUS<br/> (Category III)</td> <td class="subtitle1">Follicular neoplasm<br/> (Category IV)</td> <td class="subtitle1">Suspicious for malignancy<br/> (Category V)</td> <td class="subtitle1">Malignant<br/> (Category VI)</td> </tr> <tr> <td><strong>Pediatric</strong></td> <td><strong>–</strong></td> <td><strong>–</strong></td> <td><strong>5 to 11%</strong></td> <td><strong>0 to 3%</strong></td> <td><strong>30 to 45%</strong></td> <td><strong>30 to 70%</strong></td> <td><strong>70 to 85%</strong></td> <td><strong>95 to 99%</strong></td> </tr> <tr class="divider_bottom"> <td>Adult<sup>[1]</sup></td> <td>–</td> <td>–</td> <td>5 to 10%</td> <td>0 to 3%</td> <td>6 to 18%</td> <td>10 to 40%</td> <td>45 to 60%</td> <td>95 to 96%</td> </tr> <tr class="divider_top"> <td class="subtitle2_left" colspan="9">Individual pediatric studies:</td> </tr> <tr> <td class="indent1">Monaco et al<sup>[2]</sup></td> <td>179</td> <td>96</td> <td>0%</td> <td>7%</td> <td>28%</td> <td>58%</td> <td>100%</td> <td>100%</td> </tr> <tr> <td class="indent1">Gupta et al<sup>[3]</sup></td> <td>136</td> <td>64</td> <td>8%</td> <td>2%</td> <td>40%</td> <td>100%</td> <td>40%</td> <td>100%</td> </tr> <tr> <td class="indent1">Lale et al<sup>[4]</sup></td> <td>282</td> <td>78</td> <td>17%</td> <td>0%</td> <td>50%</td> <td>47%</td> <td>100%</td> <td>100%</td> </tr> <tr> <td class="indent1">Norlen et al<sup>[5]</sup></td> <td>66</td> <td>39</td> <td>0%</td> <td>0%</td> <td>22%</td> <td>100%</td> <td>100%</td> <td>100%</td> </tr> <tr> <td class="indent1">Buryk et al<sup>[6]</sup></td> <td>76</td> <td>36</td> <td>0%</td> <td>10%</td> <td>0%</td> <td>50%</td> <td>86%</td> <td>100%</td> </tr> <tr> <td class="indent1"><span style="white-space: nowrap;">Amirazodi et al<sup>[7]</sup></span></td> <td>207</td> <td>65</td> <td>0%</td> <td>16%</td> <td>67%</td> <td>–</td> <td>71%</td> <td>100%</td> </tr> <tr> <td class="indent1">Cherella et al<sup>[8]</sup></td> <td>430</td> <td>190</td> <td>30%</td> <td>3%</td> <td>54%</td> <td>71%</td> <td>76%</td> <td>100%</td> </tr> <tr> <td class="indent1">Heider et al<sup>[9]</sup></td> <td>46</td> <td>41</td> <td>–</td> <td>–</td> <td>36%</td> <td>20%</td> <td>100%</td> <td>–</td> </tr> <tr> <td class="indent1">Vuong et al<sup>[10]</sup></td> <td>1217</td> <td>300</td> <td>30%</td> <td>9%</td> <td>67%</td> <td>36%</td> <td>100%</td> <td>99%</td> </tr> </tbody></table></div><div class="graphic_footnotes">AUS: atypia of undetermined significance; FLUS: follicular lesion of undetermined significance; BSRTC: Bethesda System for Reporting Thyroid Cytopathology; NIFTP: noninvasive follicular thyroid neoplasm with papillary-like nuclear features.<br/>* Overall percent of patients in each histologic category for their fine-needle aspirate (based on categories defined by BSRTC<sup>[1]</sup>) who were ultimately diagnosed with a thyroid malignancy. Adult figures exclude patients with NIFTP, which has indolent behavior and is no longer classified as a malignancy. NIFTP appears to be rare in pediatric patients. Note that pediatric studies report malignancy rates only among nodules with histologic confirmation. This approach overestimates malignancy rate among nodules in lower cytological categories (nondiagnostic, benign, AUS/FLUS) due to detection bias, since resection is more likely to be performed in nodules judged to be malignant for other reasons.</div><div class="graphic_reference">References: 

<ol>
<li>Cibas ES, Ali SZ. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017; 27:1341.</li>
<li>Monaco SE, Pantanowitz L, Khalbuss WE, et al. Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol 2012; 120:342.</li>
<li>Gupta A, Ly S, Castroneves LA, et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab 2013; 98:3238.</li>
<li>Lale SA, Morgenstern NN, Chiara S, Wasserman P. Fine needle aspiration of thyroid nodules in the pediatric population: a 12-year cyto-histological correlation experience at North Shore-Long Island Jewish Health System. Diagn Cytopathol 2015; 43:598.</li>
<li>Norlen O, Charlton A, Sarkis LM, et al. Risk of malignancy for each Bethesda class in pediatric thyroid nodules. J Pediatr Surg 2015; 50:1147.</li>
<li>Buryk MA, Simons JP, Picarsic J, et al. Can malignant thyroid nodules be distinguished from benign thyroid nodules in children and adolescents by clinical characteristics? A review of 89 pediatric patients with thyroid nodules. Thyroid 2015; 25:392.</li>
<li>Amirazodi E, Propst EJ, Chung CT, et al. Pediatric thyroid FNA biopsy: outcomes and impact on management over 24 years at a tertiary care center. Cancer Cytopathol 2016; 124:801.</li>
<li>Cherella CE, Angell TE, Richman DM, et al. Differences in thyroid nodule cytology and malignancy risk between children and adults. Thyroid 2019; 29:1097.</li>
<li>Heider A, Arnold S, Lew M, et al. Malignant risk of indeterminate pediatric thyroid nodules – an institutional experience. Diagn Cytopathol 2019; 47:993.</li>
<li>Vuong HG, Suzuki A, Na HY, et al. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Pediatric Population. Am J Clin Pathol 2020; aqaa182.</li></ol>From: Bauer AJ. Thyroid nodules in children and adolescents. Curr Opin Endocrinol Diabetes Obes 2019; 26:266. DOI: <a href="https://journals.lww.com/co-endocrinology/fulltext/2019/10000/thyroid_nodules_in_children_and_adolescents.8.aspx" target="_blank">10.1097/MED.0000000000000495</a>. Copyright © 2019. Adapted with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.</div><div id="graphicVersion">Graphic 130402 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
